Advik Laboratories share news and announcements
BSE: 531686Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 19 Oct 2026. Previous close ₹2.08.
- Under BSE's graded surveillance, stage IV, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3.98 Cr5,167th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 58.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- −180.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −14.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 109.84
- Volume, BSEVolume. Shares traded on the last trading day.
- 300
Advik Laboratories share news and announcements
601 announcements, routine notices left out, newest first. Page 4 of 13.
Feb 2023
Jan 2023
23 Jan · Board meeting
Meeting on 3 Feb 2023: quarterly results12 Jan · Statement Of Investor Complaints For The Quarter Ended 31St December, 2022
Dec 2022
13 Dec · Announcement under Regulation 30 (LODR)-Change of Company Name
Nov 2022
25 Nov · Disclosure Of Related Party Transaction For The Half Year Ended September 30, 2022 Pursuant To Regulation 23(9) Of The SEBI (LODR), Regulation, 2015
2 Nov · Board meeting
Meeting on 12 Nov 2022: quarterly results
Oct 2022
12 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 012 Oct · Statement Of Investor Complaints For The Quarter Ended 30Th September, 2022
Sep 2022
13 Sep · Books Of The Company Will Remain Closed From, Friday 23Rd September, 2022 To Thursday, 29Th September 2022 (Both Days Inclusive)
9 Sep · Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding Availability Of New Name Under Section 4(5) Of The Companies Act, 2013.
Aug 2022
29 Aug · Board meeting
Meeting on 1 Sep 2022: annual general meeting29 Aug · Notice Of Board Meeting
19 Aug · Announcement under Regulation 30 (LODR)-Change of Company Name
19 Aug · Board meeting
1 Aug · Board meeting
Meeting on 12 Aug 2022: quarterly results
Jul 2022
7 Jul · Statement Of Investor Complaints For The Quarter Ended 30Th June, 2022
7 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2022
8 Jun · Revised Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2022 Pursuant To Regulation 23(9) Of The SEBI (LODR), Regulation, 2015
1 Jun · Disclosure Of Related Party Transaction For The Half Year Ended March 31, 2022 Pursuant To Regulation 23(9) Of The SEBI (LODR), Regulation, 2015
May 2022
12 May · Board meeting
Meeting on 21 May 2022: audited results
Apr 2022
23 Apr · Outcome Of Meeting Of Board Of Directors Pursuant To Reg. 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
21 Apr · Submission Of Compliance Certificate Pursuant To Regulation 40 (9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
21 Apr · CERTIFICATE UNDER REGULATION 40(9) OF THE SEBI (LISTING OBLIGATION AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 FOR THE YEAR ENDED 31ST MARCH, 2022
20 Apr · Submission Of Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
15 Apr · Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association